INOL

2017's Biotech Alert of the Year Is Here! INOL's Inojex30 is the ONLY FDA Approved Device Of It's Kind in a $9.8 Billion Market! With a Shortage of 300,000 Devices in North America Alone, Demand is Already Exceeding Supply – Making INOL The Biotech Play of the Year!

INOL's revolutionary drug delivery device could transform a $9.8 Billion industry that is expected to hit $20 Billion by 2021.
 

Hi and good evening,

Tonight is pretty special, often is the case in the small markets that we find companies that are in the process of tapping into their potential but INOL is in rarified air. This will not be a long-winded report, tonight is too important for that, instead I'll stay on point with what you need to know before tomorrow morning. In a single paragraph I'll sum up INOL for you.

The amazing INOL story in one paragraph:

INOL's device is FDA Approved; in fact, it is the ONLY FDA approved over-the-counter needle-free injection device on the market today. Last year, in North America alone there was a shortage of 300,000 such needle-free devices. Instead of a traditional syringe with a needle, INOL's device injects medicine under the skin more efficiently and painlessly. It can be used to deliver "shots" for the treatment of Diabetes, Local Anesthesia, Vaccines & Growth Hormones as well as use in Dental, Veterinary and Aesthetic / Beauty practices. This summer INOL engaged investment banking firm Maxim Group LLC, a firm with $2.8 Billion under management, to assist INOL with funding so that INOL can help fill the 300,000 device shortage. As part of INOL's agreement with Maxim, Maxim will help INOL qualify and uplist to NASDAQ Capital Market. INOL's device is also approved by Health Canada (for use in Canada) and the European Medicines Agency (for use in Europe).

Now we can get into the details, but you already know the story… and it's an incredible one! So get INOL on your screen now and be ready tomorrow morning!

INOL has been called, "2017's Top Biotech Pick of the Year". See that very detailed report here:
www.INOLReport.com

This is INOL's device, the Inojex30:



Here is the FDA's website showing you Inojex30's Product code, Device Class, Registration Number, Classification Name and that this is registered to the INOL as the owner:



INOL is anything but normal; don't let it pass you by. This could be a tremendously undervalued ground floor play. Get started on your research now and be ready for tomorrow morning.
 

Tonight's New Summer Blockbuster Play is
Inolife Technologies, Inc. (INOL)

Company Website

Detailed INOL Report
"2017's #1 Biotech Pick"

INOL Quote
 

InoLife Technologies Inc. (INOL) develops and commercializes drug delivery devices, drug delivery technologies and products for the cure and care of our global customers. INOL's flagship product, the Inojex30, is an innovative needle-free technology that delivers a fine stream of medication subcutaneously without using a needle.

INOL's Inojex30 "fine stream of medication" is less than half the radius of a needle and delivers the medicine in a more efficient, uniform manner than traditional needles.



INOL recently engaged the services of investment bank Maxim Group to bring INOL and their technology to the next level.

At the time of INOL/Maxim's agreement, INOL President stated:

"This is a very important milestone for Inolife on our path to graduating to a national stock exchange," said Mr. Michael Wright, President & CEO of Inolife. "Maxim Group is a respected full-service investment banking firm with an impressive track-record of success in helping healthcare companies grow, and we are confident that they are the right corporate finance partner for Inolife."

INOL's biotechnology has a lot going for it right now:

  • Been approved by three top regulatory agencies, including the FDA
  • Manufactures only FDA approved over-the-counter needle-free injection device
  • Expecting to uplist to NASDAQ in 2018 following recent agreement with Maxim Group LLC

Those accomplishments and benchmarks are impressive enough yet what truly places INOL in an enviable position is growing demand inside the market they operate.

  • From 2012 to 2016 the injectable market has seen an increase of 43%
  • Injectable Drug Delivery Market worth 624.50 Billion USD by 2021
  • Currently, 16 Billion injections are received worldwide annually
  • Demand exceeds supply in North America, resulting in a shortage last year of 300,000 needle-free devices

As if this wasn't enough, the technology used by INOL is being backed by prominent organizations such as the World Health Organization, Centers for Disease Control and Prevention and various groups including the Bill and Melinda Gates Foundation.

Just what is this technology? Well it's an innovative needle-free technology that delivers a fine stream of medication subcutaneously without using a needle. The injections with the InoLife Inojex are virtually pain-free and do not lead to tissue damage on long term use. The InoLife injector is a reusable device, which utilizes disposable ampoules and other accessories.

We mentioned potential earlier and the opportunities that exist for this technology are vast. INOL lists a full menu of uses for their Inojex needle-free injector and these include:

  • Diabetes
  • Local Anesthesia
  • Dental
  • Vaccines & Growth Hormones
  • Veterinary
  • Aesthetic / Beauty

It's pretty easy to understand why we are excited about INOL. The regulatory approval alone is enough to take notice, as is the market size and expected growth, so too are the many uses of this technology. Now understand that we have all three of these together in one company.

Simply put, INOL should absolutely be on the top of your trading screen tomorrow!

Like I said, tonight's play is pretty rare and pretty special. It's not often you see a company with a technology this advanced and FDA approved on the small markets.

I make no attempt to hide our love for biotech. There are few things in the small markets more beautiful and more exciting than a biotech that catches fire.

When investors find a new biotech that they can get behind it can skyrocket!

INOL could be that next biotech to capture the imagination of the small market and light it up!

Also, today INOL slid all the way down to .15, although the bid and offer has already started to rise back up.

Yesterday INOL closed at .30 and it was trading up over $2 this summer!

Today's slide could have opened a very big door.

Not only does INOL have operations that could place its value well above its current level, it could also see a significant bounce right around the corner.

A return to where it was this morning could translate to a 100% run.

A return to its summer levels could translate to a colossal run of 1,233%.

It's not often that we see situations like this; this play could be epically undervalued!

Now to be clear no one is expecting it to see a return to those summer levels in the short term, but even a fraction could translate to a massive percentage!

Like I said at the start, tonight's play is something quite special.
 

Have INOL on the top of your screen tomorrow morning.

Situations like this do not come along every day. We urge members to take Swift Action and start your research right away. We could be looking at something Exceptional!

As always, we encourage you to do further research.

ONCS – OncoSec Medical Incorporated

Trade Alert: ONCS

Hello!

 

New Trade Alert: OncoSec Medical Incorporated (NASDAQ: ONCS)

A Little About ONCS:

“OncoSec is a biotechnology company developing DNA-based intratumoral immunotherapies with an investigational technology, ImmunoPulse®, for the treatment of cancer.

ImmunoPulse® is designed to enhance the local delivery and uptake of DNA-based immune-targeting agents, such as IL-12.

In Phase I and II clinical trials, ImmunoPulse® IL-12 has demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various solid tumors and has shown the potential to reach beyond the site of local treatment to initiate a systemic immune response.

ImmunoPulse® IL-12, OncoSec’s lead program, is currently in clinical development for metastatic melanoma and triple-negative breast cancer.

The program’s current focus is on the significant unmet medical need in patients with melanoma who are refractory or non-responsive to anti-PD-1/PD-L1 therapies.

In addition to ImmunoPulse® IL-12, the Company is also identifying and developing new immune-targeting agents for use with the ImmunoPulse® platform.”

                                                                                                                                      Latest Headline:
 

ONCS released breaking news this morning that may provide an additional catalyst for upside potential.

OncoSec Appoints Industry Leader Daniel J. O’Connor to its Board of Directors

Former President and CEO of Advaxis Immunotherapies and Senior Vice President of ImClone Systems adds significant biopharma clinical, regulatory, business development, and fundraising expertise to OncoSec

SAN DIEGO, Sept. 7, 2017 /PRNewswire/ — OncoSec Medical Incorporated “OncoSec” (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the appointment of Daniel J. O’Connor to its Board of Directors. Mr. O’Connor brings more than 20 years of successful financing and licensing experience to OncoSec’s Board of Directors, most recently serving as President and Chief Executive Officer of Advaxis Immunotherapies. His appointment to the Company’s Board is effective immediately.

“Dan is a proven leader with a strong track record of success. He brings exceptional strategic and operational expertise in building thriving, successful biopharma companies, and we are pleased to welcome Dan to the Board,” said Punit Dhillon, President and CEO of OncoSec. “His history with commercializing and licensing cancer immunotherapy products will be vital as we continue to progress our lead melanoma program through clinical trials and registration.”

“OncoSec’s ImmunoPulse® IL-12 clinical program in melanoma and broader pipeline have the potential to address significant unmet needs for cancer patients with few or no treatment options,” said Mr. O’Connor. “I am excited about the potential therapeutic opportunity to combine with and enhance the existing success of the checkpoint inhibitor class of compounds. I believe that OncoSec has the leading platform to address late stage relapsed or refractory solid tumors and look forward to contributing to the advancement of the Company’s exciting portfolio.”

Most recently, as President and Chief Executive Officer of Advaxis Immunotherapies, Mr. O’Connor successfully turned around the company, raising more than $250 million in funding and transforming it into a patient-focused, leading cancer immunotherapy company.  He was also instrumental in establishing major partnerships with companies that include Amgen Inc., Merck & Co. and Bristol Myers Squibb. In addition, under his leadership, the company advanced four new cancer immunotherapy drug candidates into clinical trials, as well as several PD-1 combination clinical studies with Keytruda® and Opdivo®.  Previously, Mr. O’Connor was Senior Vice President for ImClone Systems where he supported the clinical development, launch, and commercialization of ERBITUX®, and the sale of the company to Eli Lilly in 2008. Mr. O’Connor served as General Counsel at PharmaNet (inventive Health) and was part of the senior leadership team that grew the company from a start-up contract research organization into a leader in clinical research. Mr. O’Connor is a 1995 graduate of the Penn State University’s Dickinson School of Law in Carlisle, Pennsylvania and currently serves as an Entrepreneur Trusted Advisor to its Dean. He graduated from the United States Marines Corps Officer Candidate School in 1988 and was commissioned as an officer in the U.S. Marines, attaining the rank of Captain while serving in Saudi Arabia during Operation Desert Shield. Mr. O’Connor is currently the Vice Chairman of BioNJ and was a former New Jersey criminal prosecutor.

Source: Yahoo Finance

 


OncoSec Announces Presentations at Upcoming Investment and Scientific Conferences

SAN DIEGO, Sept. 6, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be presenting at several events in September, including:

  • Rodman & Renshaw 18thAnnual Global Investment Conference
  • Johnson & Johnson Innovation + JLABS Science 1stSpeaking Series
  • Phacilitate Cell & Gene Therapy Europe 2017
  • 2ndWorld Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies

Rodman & Renshaw 18th Annual Global Investment Conference
Punit Dhillon, OncoSec’s Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 18th Annual Global Investment Conference on September 11th at 10:25 AM ET at The Lotte New York Palace Hotel in New York City.


OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors

Former Head of Global Research and Development for Merck Serono and Head of Global Medical Affairs of Bristol-Myers Squibb brings biopharma drug development, fundraising and M&A experience to OncoSec

SAN DIEGO, Sept. 5, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec” or the “Company” (ONCS)), a company developing DNA-based intratumoral cancer immunotherapies, today announced the appointment of Annalisa Jenkins, MBBS, FRCP, CEO of Dimension Therapeutics, Inc. (DMTX), to its Board of Directors. Dr. Jenkins brings over 25 years of global industry experience to OncoSec’s Board of Directors with a wealth of knowledge in advancing programs from scientific research through clinical development, regulatory approval and into healthcare systems globally. Her election to the Company’s Board is effective immediately.

“We are very pleased to have Dr. Jenkins join our Board as we believe her international biopharma drug development experience will be an asset to OncoSec as we advance our lead melanoma program and pursue collaborations with other industry leaders in oncology,” said Punit Dhillon, President and CEO of OncoSec. “Drawing on her years of experience in the biopharma industry, we believe Dr. Jenkins will provide new insights to our technology and business priorities as we continue to advance our broad clinical portfolio and achieve future growth objectives.”

“I believe OncoSec’s clinical program for ImmunoPulse® IL-12 can have a significant impact on how we approach cancer care by addressing a significant unmet need for melanoma patients that do not currently respond to anti-PD-1 treatments. In addition, I’m impressed with the Company’s commitment to advancing its innovative drug development approach, putting science and patients at the core of its mission,” said Dr. Jenkins. “I look forward to contributing to the Company’s advancement of its promising product candidates through clinical development.”  

Prior to Dimension Therapeutics, Dr. Jenkins served as Executive Vice President and Head of Global Research and Development for Merck Serono, a global division of Merck KGaA focused on biopharmaceuticals. She also led Global Medical Affairs and Quality at Merck Serono and was a member of its Pharmaceutical Executive Committee. Dr. Jenkins also had a nearly 15-year career at Bristol-Myers Squibb, attaining the role of Senior Vice President and Head of Global Medical Affairs. She began her career as a Medical Officer with the British Royal Navy during the Gulf conflict, rising to the rank of Surgeon Lieutenant Commander. Dr. Jenkins received an MBBS in Medicine from St. Bartholomew’s Hospital in the University of London and trained in cardiovascular medicine in the National Health Service (U.K.).

Currently, Dr. Jenkins serves as a director for several companies including: Ardelyx, Inc., Biothera Pharmaceutical Inc., iOX Therapeutics Limited, MedCity and Vium. She also is a committee member of the Science Board to the U.S. Food and Drug Administration, serves on the Board of the Center for Talent Innovation (U.K.) and is on the Advisory Panel of the Healthcare Businesswomen’s Association.

Source: Yahoo Finance1, Yahoo Finance2

We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term trade opportunities.

Sincerely,

AST Team

 

Disclaimer:
We have received five thousand dollars via a bank wire for the awareness of ONCS.

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

All of the information in this blog is gathered from public information released by the company.
By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold us, our editor's, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website, may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these email's. Please do your own due diligence.

TPTW – TPT Global Tech

Technology is ever changing, but the quantum leap is in the making…..

TPTW has made two extremely important moves the past few months that, layered on top of the plans laid out in the latest Share Holder letter…. have a seat…. we are about to witness history.
 

TPT Global Tech Acquires the Patent Pending Full HD Naked Eye 3D Fully Functional Experience without 3D Glasses Mobility Technology

TPTW recently completed the purchase of the technology and intellectual property of Lion Universe Technologies www.lionuniverse.com, a Los Angeles-based Mobile Technology think tank. 

The Lion smartphone is the first Full HD Naked Eye 3D smartphone ever launched in the United States. Lion Universe mobile 3D technology is patent pending. 

The smartphone will be distributed through TPT Global Tech's wholly owned subsidiary K-TEL's existing brick and mortar distribution channel in the Northwest and very soon a National and International roll out.  TPTW is building industry leading personal cellular phones designed for a wide appeal. With a business model built on innovation and progress starting with the Lion Phone technology, the company produces high-quality and easy-to-use cellular phones.

The Lion Phone was designed for consumers looking for portable and affordable cutting-edge technology.  The Company's first-generation phones come equipped with full high definition resolution screen for better viewing. This Full HD Naked Eye 3D smartphone is perfect for watching movies, playing games, even editing photos or videos.

Performance and Portability

Whether it's looking at photos, playing music, emailing or surfing the web, consumers want more from their phones. The Lion Phone raises the bar for cellular phones. For the first time ever, cellular users can enjoy quality 3D viewing with the naked eye, no glasses required, enjoying full high definition video with smooth playback.

"Consumers have been waiting for a way to watch their favorite movies in 3D, now they can watch them in the convenience of their phone and Gamers can have the leisure of playing their games without taking all that head gear with them," said Enoch Brande, President of New Product Development, Lion Universe Technology. "Throughout our company, we strive to give customers the best possible experience with our Full HD Naked Eye 3D smartphone in the US and Global markets. "

TPTW added the patent pending Full HD Naked Eye 3D smartphone hardware technology to theirportfolios of companies. This acquisition continues their commitment in moving TPT Global Tech into the Global Mobile Digital Media Technology space.

9 Days later, the company begins to utilize the newly formed relationship with AT&T.
 

Trucom, an Arizona CLEC, launches wireless mobility products and services Nationwide operating on the AT&T 4G and 5G US Wireless Mobility Network

TPTW added the patent pending Full HD Naked Eye 3D smartphone hardware technology to theirportfolios of companies. This acquisition continues their commitment in moving TPT Global Tech into the Global Mobile Digital Media Technology space.

TPTW's Arizona based wholly owned subsidiary CLEC Trucom recently completed its AT&T Mobility wireless certification. Trucom is now positioned to launch Trucom Wireless and Broadband Services Nationally with its strategic partner AT&T, utilizing AT&T's mobility 4G and 5G National network. 

TruCom (www.trucom.com) is a Facilities Based Competitive Local Exchange Carrier (CLEC) headquartered in Phoenix, AZ.  Founded in 2006 for the purpose of operating a state-of-the-art Fiber Optic Network, Trucom operates its own carrier class Fiber Optic Network, state-of-the-art Wireless Point-to-Point network, and Patent Pending proprietary "Bulletproof" technology seamlessly integrating the two.

TruCom offers Phone, Internet, Fiber Optic, Wireless, Hosted PBX, Wi-Fi, Wi-Max, Engineering, Cabling, Wiring and Cloud services.  With a penchant for pushing the envelope, TruCom has pioneered innovative, hosted firewall and managed MPLS service technologies (SuperCore MPLS™) and was the Industry first to engineer patent-pending failover services utilizing our own fiber optic and wireless networks to guarantee business continuity and service uptime.  

Co-located in multiple Local Serving Offices and Points of Presence (POP's) in the primary Data Centers in the market, TruCom's extensive Fiber Optic Network runs through the heart of the most densely populated corridors of the Greater Phoenix Metro Area. Their Wireless Point to Point and Point to Multipoint Network is fed by the infinitely scalable capacity of the Fiber Optic Network and consists of more than 16 Major Access Points. 

"We here at TPT Global Tech are very pleased to add the patent pending Full HD Naked Eye 3D smartphone hardware technology to our portfolios of companies. This acquisition continues our commitment in moving TPT Global Tech into the Global Mobile Digital Media Technology space. We also look forward to continuing our working relationship with Linda Kelly who will continue to head Lion Phone division as its CEO and her outstanding tech team moving forward," said Stephen Thomas, CEO of TPT Global Tech Inc.

A few important points to keep in mind about TPTW:

  • TPTW reported over $2Mill in Revs for 2016
  • TPTW already showed over $700K in revs for Q1 of 2017
  • TPTW is sporting a TINY FLOAT of only 4.4Mill shares


So, now that we have a very interesting picture of TPTW's future direction, and the fact that last time we discussed the chart and letter of share holders, we witnessed a 600% uptrend over the next thre days….this should be interesting.

Please start your research on TPTW right away and enjoy.

Disclaimer:
We have received five thousand dollars via a bank wire for the awareness of TPTW.

All of the information in this blog is gathered from public information released by the company.
By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold us, our editor's, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website, may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these email's. Please do your own due diligence.

Could Global Trade Growth Push This Small-Cap Higher?

This Undervalued Freight Transportation Company (listed below) is Making Some Big Changes, and It’s Poised to Surprise Investors in 2017

Despite what many believe, global trade is set to have some momentum in 2017 and one small NASDAQ company could be ready to take advantage of this shift in the marketplace. According to the World Trade Organization’s latest World Trade Outlook Indicator (WTOI), there may have been some continued momentum, from the fourth quarter of 2016, into the first quarter of 2017. This indicator provides data that include automobile sales, export orders, air freight, container shipping, electronic components and agricultural materials. Therefore, this tool is a prime indication of the trends of global trade.

Here’s a look at the recent WTOI reading, in late 2016:

Source: WTO

In addition to this above trend growth, as indicated above, the World Trade Organization (WTO) projected that world merchandise trade growth is set to grow between 1.8% and 3.1% in 2017. This forecasted growth rate could suggests increased volume, which could be beneficial for many companies.

With the potential growth in world trade, this translates to a potential growth in the shipping industry. However, some shipping companies are overvalued, and as you all may know, you generally want to buy low and sell high.

Now, more specifically, global trade growth should benefit the deep sea freight transportation industry. According to the St. Louis Federal Reserve Bank’s economic research, the producer price index in the deep sea freight transportation industry has been trending higher, as shown in the chart below.

Source: FRED

This means the deep sea freight transportation industry has been experiencing higher price levels, which could mean a potential increase in revenues, if the trend continues. Not only that, the Baltic Dry Index, which takes into account rates for ships carrying dry bulk commodities, recently hit over more than a two-year high, indicating there could be increasing demand for transporting major raw materials by sea.

 

Source: Bloomberg

The Baltic Dry Index has been trending higher, up as much as 50% at its highs in the past 12 months, providing an indication that deep sea transportation companies engaged in dry bulk shipping could potentially ride off the coattails of the potential increase in demand for these services.

With all the industry and world trend set to potentially grow in 2017, these developments have uncovered some interesting opportunities in some publicly-trade companies in the deep sea freight transportation industry. However, there’s one that stock that stands out, which could have an impressive upside potential. Let’s move onto an in-depth look at Seanergy Maritime Holdings Corp. (NASDAQ:SHIP).

Seanergy Maritime Holdings (NASDAQ:SHIP) is an international deep sea transportation shipping company primarily focused on providing marine drybulk transportation services. That in mind, SHIP owns and operates dry bulk vessels to do so. The company owns and operates a modern fleet of ten dry bulk carriers, which consists of eight Capesizes and two Supramaxes, and its fleet has a combined cargo-carrying capacity of over 1.5M dwt. The company recently acquired another Capesize fleet, which upon its delivery, would increase its modern fleet to 11 drybulk carriers. As we’ve already stated earlier, the potential increase in demand coupled with the projected growth rate of global trade means Seanergy is poised to grow its revenues and earnings, potentially translating to an increase in its stock price.

Seanergy’s Fleet is Strong

Source: Company’s Website

SHIP‘s current eleven vessel fleet is strategically placed in various parts of the world, such as Africa, South America, Asia and the middle east. With that in mind, these placements  are focused around some producers of major raw materials which means NASDAQ:SHIP is poised to take advantage of the demand for drybulk sea transportation. Among the company’s largest ships, recently acquired Capesize vessel to be renamed Partnership, which is expected to be delivered in June 2017. The Partnership has a capacity of 179K dwt. With the potential increase in demand for major raw materials and SHIP’s placement of its shipping vessels, its revenues could continue to rise.

According to SHIP Chief Executive Officer Stamatis Tsantanis, “We are very pleased to announce another acquisition of a modern Capesize vessel. This high quality Capesize vessel marks our first acquisition of 2017 and follows the successful acquisition and delivery of two sistership Capesizes in the fourth quarter of 2016. In addition, this purchase allows us to expand further our sizable position in the Capesize segment. We strongly believe that the Capesize segment represents the best fundamentals in the dry bulk industry and we will continue to actively pursue accretive acquisition opportunities of quality Capesize vessels with an aim of increasing value for our shareholders.”

Source: Company’s Website

This acquisition of a high-quality Capesize vessel allows the company to expand and bolster its position in the Capesize drybulk transportation segment. As the company increases its vessel size, it could take on more business from producers of major raw materials, translating into higher potential sales and profits. That said, if market participants catch wind of this, the market could price this in, potentially leading to a higher stock price. Thereafter, if its financial statements continue to show growth, SHIP could run higher.

Seanergy Could Increase its Equity, and Strengthen Balance Sheet

In March 2017, Seanergy announced it entered into a definitive agreement with one of its senior lenders in order to repay a credit facility, early. Consequently, SHIP expects this early repayment to result into a potential material gain and an increase in equity. Specifically, this gain is projected to be over $11M, representing around 29% of the outstanding facility. In turn, this transaction could drive SHIP‘s total equity up by over 30%, on an adjusted basis.

When speaking about this transaction Tsantanis said, “We are very pleased to announce another important transaction for the Company, which should result in significant accretion for our shareholders. Not only are we growing our fleet but we are streamlining our capital structure to be in a position to further capitalize on a strengthening dry bulk market. In the past six months Seanergy has successfully raised funds from the equity capital markets and used this capital for highly accretive and productive purposes to grow its platform and enhance shareholder value.”

Moreover, the CEO showed confidence in the company and believes the recent accretive acquisitions are consistent with its business strategy. Tsantanis also noted that the company is looking into additional transactions that are expected to enhance the value to shareholders and therefore the Company’s stock price.

The company looks like it could strengthen its balance sheet and income statement, potentially creating more value to SHIP stockholders.

Moving on, the company had some notable achievements during the 2016 fiscal year.

Seanergy Maritime Holdings 2016 Financial Highlights

Data Provided by Morningstar

If you look at the chart above, notice how Seanergy Maritime Holdings (NASDAQ:SHIP) has been consistently growing its revenue since the third quarter of the 2015 fiscal year. That in mind, the company grew its revenue from just over $2.6M in the third quarter over 2015, to over $8.6M in the third quarter of the 2016 fiscal year.

Seanergy continued its strong growth in its income statement during the fourth quarter of 2016. SHIP generated net revenue of $10.9M during the fourth quarter of 2016, and $34.7M for the full year. Additionally, what may be more attractive to investors was its growth in its total shareholders’ equity, which grew to $30.8M in 2016, up from $23.3M in 2015, or a growth rate of 32%. Not only that, but with the company’s acquisition of two modern Capesize vessels in 2016, and consequently, its increase its dwt capacity by 30%. In turn, this indicates SHIP has the ability to further grow its revenues in 2017. Additionally, with its recent early repayment of a credit facility, SHIP could grow its total shareholders’ equity even more in 2017.

SHIP Could Rise Soon

The potential rise in global trade and demand for major raw materials and deep sea freight transportation companies focused on drybulk shipping could move in tandem to those growth rates, which would allow companies like Seanergy Maritime Holdings (NASDAQ:SHIP) to generate higher revenues. Micro- and small-cap deep sea freight transportation stocks, such as SHIP, have large upside potential due to the these potential changes in the industry. SHIP had some developments that could potentially be indications that the company could grow its revenues and total stockholders’ equity. If Seanergy continues with its business strategy, and to increase shareholder value, this stock could start moving higher.


Sincerely,

Awesome Stock Tips

 

Disclaimer:

We have received ten thousand dollars for the awareness of SHIP.

BLTO – Bingo Nation Inc.

Bingo Nation Inc. OTC: BLTO


The house always wins.

That's why gambling companies are such safe bets.
The gambling industry is projected to grow 5.7% a
year through 2022 – to reach $635 billion.

To put that in perspective, if you created a country
named "Casinoland" that got all of its GDP from
gambling, and absolutely nothing else… it would be
the 21st richest country in the world.

$635 billion is approximately the GDP of Saudi Arabia, and well north of Argentina, Sweden, Norway, or Austria.

But, as impressive as that is overall, Indian Gaming growth in particular puts that to shame. It's growing twice as fast as the industry as a whole… and Indian Gaming is now larger than Las Vegas and Atlantic City combined.


This isn't your grandfather's reservation casino.
Today,
Bingo Nation Inc. (OTC: BLTO) Indian Gaming is big, big business. To the tune of $28.9 billion
in 2014, and rising fast.

Until recently, though, there wasn't much
you could do about it. Unless you were
the elder of a Native American tribe,
you were completely locked out of this
rapidly expanding, wildly profitable
industry.

Until recently — being the key.

Today, there is one company — Bingo Nation (OTC: BLTO), in existence for less than a year — that gives you a direct in to the Native American gambling industry.

Bingo Nation Inc. (OTC: BLTO)

 

In fact, it's the only pure play in the market today. There is, simply put, nowhere else you can directly invest purely in Native American casinos.

That fact alone makes Bingo Nation one of the most promising young companies in the world. When there's only one way to invest in a massive, fast-growing industry, that play will eventually attract attention.
 

But what takes Bingo Nation from unique, solid choice to one of the hottest properties on the market are all the other advantages the company possesses.

Like the fact that Bingo Nation is revolutionizing the way gambling works… making it possible to entirely legally gamble on your phone, or in the comfort of your easychair in front of the TV.

Or that Bingo Nation is the first company that's bridging different casinos and tribes, tapping into the gambling action across dozens of sites. And, with exponentially-increasing takes, Bingo Nation is able to produce eye-popping jackpots like no other game.

Or that Bingo Nation has figured out a way to combine two games into one play — doubling its opportunities to capture attention. And, not coincidentally, capturing a large and growing share of the younger gambling population.


It's little surprise, then, that Bingo Nation is projected
to generate revenue that's 1,344% above its current
market cap.

That means, if the price of the stock just kept up with revenue growth, it would increase 1,344% by the end
of the year.

Of course, that's not how stock prices actually work.
In actuality, market caps are almost always much
larger
than a year's revenue — usually by orders of magnitude.


In other words, 1,344% growth in almost certainly too conservative an estimate. True growth will likely be multiples higher.

And it's all thanks to the revolutionary new platform and business model that Bingo Nation has invented — which you'll learn more about in a moment.

But, perhaps even more impressive, is how incredibly safe this business model is.

If You Had Bought Gambling Stocks In 2016 You Would Have Beaten The Market By 100% And Made An Easy 45% Return In Just 14 Months

But With Special Tax Breaks And Management Projecting $30,000,000 A Week In Revenue, Bingo Nation Could Put Other Gambling Stocks To SHAME!

Bingo Nation Inc.OTC: BLTO


The House's House

The House always wins, of course.

Except when it doesn't… because the truth of the matter is, every game in a casino is guaranteed to make money… but the whole casino isn't.

Because casinos have all sorts of extra expenses: they have to run hotels and restaurants at the same time — often at steep discounts — which are far from safe bets.

They also provide entertainment — from magic acts like Penn and Teller, to music acts like Wayne Newton, to hosting fight nights. None of that is cheap.

And, of course, casinos are constantly competing against each other. As soon as a new one opens, an older one loses business.

Coins


That's why casinos aren't sure things. They shut down. They go bankrupt. (Just ask the current resident of the White House.)

But the companies that supply the games to casinos… that's another story.

Because the casino games themselves always win.

 

Just take a look at Scientific Gaming Industries (Nasdaq: SGMS) — one of the stalwarts of the industry that manufactures slot machines. From its early stages — when it was young, like Bingo Nation is today — it returned 2,093% in a short stretch: Nasdaq Stock Chart

Or Galaxy Gaming Inc. (OTC: GLXZ), up 230% in the past five years:

Galaxy Gaming Inc. stock chart

Or Aristocrat Leisure (OTC: ARLUF), rallied over 1,344% since 2003:

Aristocrat Leisure stock chart


The examples are endless. If you make the actual machines that casinos use, well, you basically have a license to print money. Heck – you even get to decide what frequency machines pay out at – meaning, you get to decide, ahead of time, just how much money you make!

 

But — and this is key — Bingo Nation (OTC: BLTO) is different. It's got an even rosier outlook.


And that's because — unlike all the gaming manufacturer's above — Bingo Nation isn't competing in an already-established field. It's introducing an entirely new type of action into Indian casinos. One that should prove even more lucrative than what's come before.

Gambling Stocks Have Delivered MASSIVE Profits Recently…

  • Scientific Games Corp (SGMS): Up 145%
    in one year
  • Galaxy Gaming Inc. (GLXZ): Up 167% in
    just 12 months
  • Boyd Gaming Corporation (BYD): Up a
    smoking hot 250%!

Could BLTO be… …the gambling stock to finally make YOU rich?

 

Bingo coupon

The simplest way to describe Bingo
Nation's product is: It's like a lottery.

Only it's so much more.

It's true — the base game works similar
to a state lottery.

It takes in money, gives out tickets — in
the form of bingo sheets — and hands
out a variety of prizes of varying size.

Bingo Nation machines can print out up to 100 million unique tickets each week. Think about that. That's up to $100 million in revenue, every week — just on the main game.

Bingo Kiosks

Half the proceeds are handed out as winnings. The other half gets split
between the casino and Bingo Nation.

In other words, if Bingo Nation sold 100 million tickets in a week, it would get to
keep $12.5 million every week. As pure
profit. And that's for a company that, at
least at the time of writing, only has a $13 million market cap.

You're starting to see why Bingo Nation has
the potential to blast 1,344% higher in short
order.

But — and this is key — what you've heard
about so far is only the beginning.

 

1.Like Powerball, But Better
 

You know when the nation starts paying attention to lottery jackpots, right?

When a Powerball jackpot starts getting huge. Usually, once it passes $100 million, people take notice.

And you get news stories of gas stations with lines out the door, with everyone and their mother lining up for a chance at that juicy jackpot.

The way Powerball jackpots get so large is by combining multiple states. You can't get that much money lined up only collecting in New Jersey… but if you add all of New England and the mid-atlantic states down to Georgia — now you've got a Powerball jackpot!


And huge jackpots work. Because they grab everyone's attention.

Jackpot

Powerball jackpots have been a huge boon for state lotteries. They've increased interest, increased revenue.

What Powerball has never done is increase casino profits. Until today.

That's because Bingo Nation finally figured out how to create a Powerball-like system for casinos.

All of their machines — across every casino — are linked together for certain drawings, their "Powerball" drawings.

If someone wins the first one, great — they get a huge payday.


But if a jackpot rolls over once… and then twice… well, it works just like it does in state lotteries. You get a feeding frenzy.

Only this frenzy isn't made up of hopeful citizens. You're dealing with folks who have come out specifically to gamble.

 

But if you think this is the end of the story… just wait. It gets better.


2.Armchair Casino
Play Bingo Online

Get this: Bingo Nation's users don't even
have to be inside the casino to play.

Once they have their ticket, they can watch online, or on TV, for the weekly drawings.

That's right — Bingo Nation has brought
legal gambling to your living room.

In fact, you don't even have to go into the casino at any point. You can just give your player's card to someone else, who can
place your bet for you.

This is, to put it succinctly, a game-changer.
It might be the most revolutionary innovation to hit casinos since there have been casinos. This marks a potentially drastic increase in players… and gaming revenue.


But, if you think Bingo Nation is resting on its laurels, think yet again.

 

3.Drawing In The Next Generation


The biggest problem casinos face is demographics: Millennials.

The people who frequent casinos get older and older… but, in order to make a good business, game makers need to captivate the next generation.

So far, no one has figured it out. Except Bingo Nation.

In addition to its bingo lottery games — which appeal to an older generation — Bingo Nation has a second, hybrid way to play.


Think of it as a lottery with an instant payoff, like a scratch ticket. And this form of gambling has proven very popular with younger players.

In addition, Bingo Nation is developing mobile app games for later this year. They'll be available on both Android and iPhone, and they're free to play.

available on android and iphone

These apps are going to get more players familiar with the games — an important barrier to lots of potential customers. If they can get to know the game safely, for free, in private, they're much more likely to give it a shot in public.

But — perhaps even more importantly — these apps will work as a cheap, accurate form of research and development. Bingo Nation can try out tweaks — or entirely new games — with no risk, and see if the public has an appetite for them.

If so, they can put them on casino floors. And if a game is a flop, the company didn't have to spend hundreds of thousands, or millions of dollars developing it.

Free apps like this are the wave of the future. It's easy to imagine an upcoming time, of looser restrictions and regulations, when brick-and-mortar casinos go away and apps like these take over all gambling.

That's a far-off vision for now, but Bingo Nation is already thinking ahead. And, with the incredible, powerful market research these apps can provide today, they're a no-brainer.

The only surprising thing is that more companies haven't done this already.


Bingo for the Hi-Tech Generation: Why Bingo Nation Is the Future of Gaming

 
Bingo Nation is much more than a stock that promises massive returns for early investors.It's also a high tech company set to disrupt the entire gaming industry.

 
Bingo Nation has developed a series of patent-pending gaming technologies, including self-serve kiosks, player cards, and a mobile app that lets players check their stats on their phone.
 

All of Bingo Nation's patents have been inspected and approved by Gaming Laboratories International, the world’s leading electronic games testing organization.

What does that mean for investors?


That all of Bingo Nation's gaming technologies are ready to go to market and start pumping out profits.

Investor's Snapshot
Bingo Nation Inc. (OTC: BLTO)

Bingo Nation Inc.
  • Rating: STRONG BUY
  • Confidence: HIGH
  • First profit target: 200% gainfirst half, let the rest ride
  • Second profit target: 1,344% gainsecond half

 

4.The Only Game In Town

Don't forget, Bingo Nation is exclusively catering to Indian casinos. For good reason — they make up the largest gambling segment in America.

Yet there is almost no way to invest in them. You can't own parts of the casinos. And the very few publicly-traded companies that supply Indian casinos do so as a small part of a larger business.

The only way to get a piece of this $28.9 billion industry is through Bingo Nation (OTC: BLTO). It's got all the tools in place, and the right people running the company.

And there's no better time to get in than right now.

This Is Your Moment.

Why now?

Simple — Bingo Nation has only been around a short while – so it's still cheap.

Bingo Nation Kiosks

In January 2017, Bingo Nation received its certification
from Gaming Laboratories International (GLI). That's the governing body that decides what companies can install gambling hardware and software on casino floors.


In other words, only this January, the key went in the ignition and the motor started running.

Already, machines are being installed across the nation. And, as more and more casinos see the potent combination of "Powerball" style jackpots, play-at-home potential, along with hybrid lottery and instant games, the steady drumbeat of orders will turn into an avalanche.

And all of this is before the apps are released this summer… introducing an entirely new audience — and generation — to Bingo Nation games.

In other words, the stock is cheap today because there isn't even a single quarter's worth of profits to talk about yet.

But that won't be true in three months. And it certainly won't be true in six months.
 

MoneyBingo Nation is planning a 3,000-kiosk rollout in 2017.
And up to an average of $30 million in ticket sales every week.

That's equal to $3.75 million in ticket profits every week
to Bingo Nation. Some of that will be eaten up by initial outlays for the kiosks and development – but there's no doubt, that's serious money for a company with a tiny
$13.5 million market cap.

Simply put, the cap can't stay this low for long. As 2017 witnesses the burgeoning success of Bingo Nation, inve-
stors are going to come rolling in. A company that can
bring in $195 million in revenue in its first full year can
easily justify a market cap of over $1 billion. With the astonishing growth such a situation implies, $1 billion is probably too cheap a price!


But there's no need to be greedy. We can build in
some unforeseen bumps… a misfortune or two… and
say that a mere 1,344% increase is enough to hope for.

That would just mean a $195 million market cap. That
would just equal revenue. That would still be an insanely cheap stock.

But it would be an insanely great investment at today's valuations. Before Bingo Nation becomes buzzworthy throughout the $28.9 billion Indian casino industry, you
want to get in. This is still a ground-floor opportunity.


By the second half of 2017, the big money will likely already have been made.


If you're looking for meaningful profit in your investment portfolio, you NEED to research Bing Nation (OTC: BLTO) today.

If you're looking for a opportunity to possibly earn a 1,344% return

THIS IS YOUR TIME TO ACT. RIGHT NOW!

The Native American Gaming Industry Generates $28.9 Billion Tax-Free Income Every Year.

It Has Been Nearly Impossible For Investors To Access. Until Now.

 

The gambling industry is on fire, with 2016 delivering absolutely explosive returns.

Annual gambling revenue has skyrocketed to $99.6 billion — approaching the $100 billion mark for the first time ever.

The Dow Jones U.S. Gambling industry index rose 40% in 2016 — easily beating the overall stock market's return of 20.8%. If you had invested $100,000 in the gambling index on January 3, 2016, you would made made a cool $40,000 in just 12 months.

And if you had invested the same amount in the biggest gainers in the industry, you'd have made a mind-blowing $167,000.
 

That destroys the $20,770 you'd have earned investing in the Dow.


But there is one stock that promises to deliver even bigger returns than these.

A stock that could blow the Dow out of the water by 10x.

A stock that that inject a quick $50,000, or even $100,000 into your brokerage account if you get in early.

A stock with so much upside potential, it could easily be the biggest gainer of 2017.


Opportunities like this do not last long.

Bingo Nation is has the potential to grow into one of the biggest gaming companies in the nation.

Its platform has been tested and certified by GLI, the leading electronic gaming testing and inspection company.

It is set to roll out over 3,000 bingo card kiosks across the country, projected to bring in up to $30 MILLION in weekly revenue.

Its income is largely tax exempt, being a Native American Tribal enterprise.

It is part of a sector that had an average return of 40% last year, and the top-performers in the same industry, like Galaxy Gaming, delivered 150% or last year alone.

…and that's WITHOUT the huge tax advantages that Bingo Nation enjoys.

Stocks like this have given investors 200%, 300%, even 500% returns.

If you've been wanting a quick injection of cash into your investment portfolio…

BINGO NATION INC. (OTC: BLTO)

If want to profit you NEED to take a look at this stock right now — BEFORE it announces its next quarterly earnings statement!

…For possible gains of up to 1,344%, research BLTO right now!

Sincerely,

007

Disclaimer:
We have received five thsnd dlrs via a bank wire for the awareness of BLTO

We have not confirmed the accuracy of the information published in this report, please do your own Due Dilligence and always advise with a registered investment advisor before investing or trading any mentioned security.

By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor's, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be c.ompensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these reports. Please do your own due diligence.

 

Hot Stock Alerts for 2015

Date Ticker Open HOD Close % change from open to HOD % change from open to EOD New hights afer alert % from alert to new high
1/2/2015 CYLC 0.002 0.012 0.008 500% 300%    
1/5/2015 INKN 0.0025 0.005 0.0037 100% 48%    
1/8/2015 FEWP 0.002 0.0061 0.003 205% 50%    
1/9/2015 XPRT 0.0036 0.018 0.0084 400% 133%    
1/12/2015 PEFF 0.004 0.01 0.003 150% -25%    
1/13/2015 THNS 0.165 0.185 0.1601 12% -3%    
1/14/2015 GNBA 0.004 0.02 0.006 400% 50%    
1/15/2015 SITO 0.194 0.215 0.18 11% -7%    
1/16/2015 IYXI 0.0039 0.012 0.0035 208% -10%    
1/20/2015 OOIL 0.1 0.112 0.105 12% 5%    
1/21/2015 AACS 0.0038 0.008 0.0043 111% 13%    
1/22/2015 AXXE 0.2165 0.217 0.19 0% -12%    
1/28/2015 STVF 0.4249 0.425 0.4 0% -6%    
1/28/2015 NGMC 0.0104 0.0143 0.0077 38% -26%    
2/3/2015 AAGC 0.0022 0.0045 0.0035 105% 59%    
2/4/2015 RCHA 0.001 0.0163 0.0148 1530% 1380%    
2/5/2015 SWMM 0.19 0.45 0.25 137% 32%    
2/9/2015 NPWZ 0.0099 0.012 0.01 21% 1%    
2/11/2015 LIVE 3.4 3.87 3.8 14% 12%    
2/11/2015 DRMC 0.009 0.0144 0.0065 60% -28%    
2/17/2015 OOIL 0.0847 0.087 0.087 3% 3%    
2/19/2015 GMND 0.0019 0.009 0.005 374% 163%    
2/23/2015 ETBI 0.0365 0.04 0.0372 10% 2%    
2/24/2015 DIGX 0.0022 0.0026 0.0018 18% -18%    
2/25/2015 STHC 0.0388 0.0445 0.0445 15% 15%    
3/4/2015 PSID 0.027 0.028 0.0254 4% -6%    
3/6/2015 XDSL 0.0007 0.0007 0.0006 0% -14%    
3/11/2015 CWNR 0.0016 0.003 0.0027 88% 69%    
3/13/2015 NVNT 0.002 0.0078 0.0026 290% 30%    
3/20/2015 FLKI 0.013 0.0199 0.014 53% 8%    
3/26/2015 HHWW 1.3 2.14 1.3 65% 0%    
3/30/2015 TXHD 0.055 0.056 0.0425 2% -23%    
3/31/2015 CMXC 0.3099 0.31 0.29 0% -6%    
4/2/2015 HOMS 0.7 1 0.65 43% -7%    
4/7/2015 BETS 0.0016 0.0017 0.0014 6% -13%    
4/9/2015 LGBI 0.0019 0.0025 0.002 32% 5%    
4/10/2015 XTRM 0.006 0.0078 0.0061 30% 2%    
4/13/2015 FLSR 0.195 0.2 0.18 3% -8%    
4/15/2015 VMRI 3.17 3.19 3.079 1% -3%    
4/17/2015 PSID 0.022 0.022 0.0211 0% -4%    
4/27/2015 TPHX 0.65 0.7 0.671 8% 3%    
4/28/2015 MGON 0.0022 0.004 0.0038 82% 73%    
4/30/2015 MCGI 0.0018 0.003 0.0021 67% 17%    
5/3/2015 BABL 0.0034 0.0063 0.0046 85% 35%    
5/6/2015 WSRA 0.0058 0.0085 0.005 47% -14%    
5/8/2015 LIBE 0.0016 0.0018 0.0014 13% -13%    
5/11/2015 IGRW 0.0023 0.0029 0.0021 26% -9%    
5/12/2015 PMCB 0.155 0.1635 0.162 5% 5%    
5/13/2015  GRCU 0.0013 0.0015 0.0013 15% 0%    
5/14/2015 AXXE 0.0729 0.0729 0.065 0% -11%    
5/18/2015 NRDS 0.0022 0.0074 0.0035 236% 59%    
5/19/2015 SPYR 0.486 0.52 0.52 7% 7%    
5/20/2015 EWRC 0.0338 0.035 0.027 4% -20%    
5/29/2015 TPHX 0.22 0.2321 0.2199 6% 0%    
6/4/2015 GOFF 0.0016 0.0026 0.002 63% 25%    
6/12/2015 INPH 0.77 1.33 1.17 73% 52%    
6/16/2015 FREE 0.125 0.179 0.091 43% -27%    
6/23/2015 TPHX 0.0476 0.0615 0.0545 29% 14%    
6/24/2015 DPW 0.88 1.35 1.2 53% 36%    
6/24/2015 DNRG 0.0198 0.0885 0.073 347% 269%    
6/25/2015 RXMD 0.0099 0.049 0.0422 395% 326%    
6/26/2015 CLRX 0.751 0.933 0.833 24% 11%    
6/30/2015 USMJ 0.0122 0.017 0.0119 39% -2%    
6/30/2015 CATV 0.005 0.019 0.0169 280% 238%    
7/1/2015 SHIP 0.56 1.04 0.68 86% 21%    
7/6/2015 AXMM 0.023 0.071 0.06 209% 161%    
7/8/2015 FORD 0.7 0.89 0.739 27% 6%    
7/9/2015 TSOI 0.0042 0.023 0.011 448% 162%    
7/17/2015 UMAX 0.0041 0.005 0.004 22% -2%    
8/16/2015 TXHD 0.011 0.014 0.012 27% 9% 0.07 536%
9/4/2015 RLTR 0.004 0.0065 0.0029 63% -28%    
9/21/2015 CALI 0.874 1.35 1.081 54% 24%    
10/14/2015 MLPH 0.0065 0.0215 0.016 231% 146%    
10/16/2015 MCTC 0.005 0.02 0.0079 300% 58%    
10/20/2015 VPLM 0.11 0.129 0.1149 17% 4%    
10/26/2015 KDKN 0.0025 0.0365 0.008 1360% 220%    
10/28/2015 PFHS 0.645 0.7098 0.6838 10% 6% 4.11 537%
10/30/2015 DYNV 0.0025 0.013 0.005 420% 100%    
11/2/2015 FZRO 0.048 0.051 0.0417 6% -13%    
11/3/2015 VTMB 0.0007 0.005 0.0016 614% 129%    
11/6/2015 ESYL 0.0029 0.01 0.0055 245% 90%    
11/23/2015 BWVI 0.159 0.232 0.22 46% 38%    
12/3/2015 AMFE 0.0079 0.008 0.0068 1% -14%    
12/16/2015 SIMH 0.0037 0.009 0.0046 143% 24%    
12/28/2015 SBFM 0.0045 0.0118 0.0107 162% 138%    
12/28/2015 RCHA 0.0001 0.0005 0.0003 400% 200%    
12/30/2015 NSPR 0.81 0.9575 0.8675 18% 7%    
12/31/2015 LEI 1.85 10.65 7.22 476% 290%    
        Total: 12378% 5010%    

Disclaimer:
Stockchat LLC has previously received 28,000 dollars for the awareness of THNS from a third party which has since expired.
Stockchat LLC has previously received 10,000 dollars for the awareness of SITO from a third party which has since expired.
Stockchat LLC has previously received 15,000 dollars for the awareness of OOIL from a third party which has since expired.
Stockchat LLC has previously received 41,000 dollars for the awareness of AXXE from a third party which has since expired.
Stockchat LLC has previously received 13,000 dollars for the awareness of STVF from a third party which has since expired.
Stockchat LLC has previously received 27,000 dollars for the awareness of NGMC from a third party which has since expired.
Stockchat LLC has previously received 8,000 dollars for the awareness of NPWZ from a third party which has since expired.
Stockchat LLC has previously received 4,000 dollars for the awareness of LIVE from a third party which has since expired.
Stockchat LLC has previously received 14,000 dollars for the awareness of DRMC from a third party which has since expired.
Stockchat LLC has previously received 15,000 dollars for the awareness of ETBI from a third party which has since expired.
Stockchat LLC has previously received 60,000 dollars for the awareness of DIGX from a third party which has since expired.
Stockchat LLC has previously received 15,000 dollars for the awareness of STHC from a third party which has since expired.
Stockchat LLC has previously received 7,000 dollars for the awareness of XDSL from a third party which has since expired.
Stockchat LLC has previously received 32,000 dollars for the awareness of CMXC from a third party which has since expired.
Stockchat LLC has previously received 90,000 dollars for the awareness of XTRM  from a third party which has since expired.
Stockchat LLC has previously received 40,000 dollars for the awareness of FLSR from a third party which has since expired.
Stockchat LLC has previously received 14,000 dollars for the awareness of VMRI from a third party which has since expired.
Stockchat LLC has previously received 23,000 dollars for the awareness of PSID from a third party which has since expired.
Stockchat LLC has previously received 40,000 dollars for the awareness of TPHX from a third party which has since expired.
Stockchat LLC has previously received 5,000 dollars for the awareness of PMCB from a third party which has since expired.
Stockchat LLC has previously received 47,000 dollars for the awareness of AXXE from a third party which has since expired.
Stockchat LLC has previously received 5,000 dollars for the awareness of SPYR from a third party which has since expired.
Stockchat LLC has previously received 48,000 dollars for the awareness of EWRC from a third party which has since expired.
Stockchat LLC has previously received 46,000 dollars for the awareness of TPHX from a third party which has since expired.
Stockchat LLC has previously received 6,000 dollars for the awareness of UMAX from a third party which has since expired.
Stockchat LLC has previously received 13,000 dollars for the awareness of TXHD from a third party which has since expired.
Stockchat LLC has previously received 6,000 dollars for the awareness of RLTR from a third party which has since expired.
Stockchat LLC has previously received 10,000 dollars for the awareness of VPLM from a third party which has since expired.
Stockchat LLC has previously received 10,000 dollars for the awareness of PFHS from a third party which has since expired.
Stockchat LLC has previously received 6,000 dollars for the awareness of FZRO from a third party which has since expired.
Stockchat LLC has previously received 7,000 dollars for the awareness of BWVI from a third party which has since expired.
Stockchat LLC has previously received 14,000 dollars for the awareness of AMFE from a third party which has since expired.
Stockchat LLC has previously received 6,000 dollars for the awareness of SIMH from a third party which has since expired.
Stockchat LLC has previously received 9,500 dollars for the awareness of VTMB from a third party which has since expired.
Stockchat LLC has previously received 16,000 dollars for the awareness of SBFM from a third party which has since expired.
Stockchat LLC has not been compensated in any way or form for the awareness of CYLC, INKN, FEWP, XPRT, PEFF, GNBA,
IYXI, AACS, AAGC, RCHA, SWMM, GMND, CWNR, NVNT, FLKI, HHWW, HOMS, BETS, LGBI, MGON, MCGI, BABL, WSRA,
LIBE, IGRW, GRCU, GOFF, INPH, FREE, DPW, DNRG, RXMD, CLRX, USMJ, CATV, SHIP, AXMM, FORD, TSOI, CALI, MLPH,
MCTC, KDKN, DYNV, ESYL, NSPR, LEI